Fee J P, Collier P S, Dundee J W
Acta Anaesthesiol Scand. 1986 May;30(4):337-40. doi: 10.1111/j.1399-6576.1986.tb02426.x.
It has been generally assumed that the bioavailability of different formulations of intravenous diazepam is identical. In a within-subject crossover study using eight healthy volunteers, we have found that both the initial and the overall plasma diazepam levels are significantly lower after both emulsion (Diazemuls) and micelle preparations than after an organic formulation (Valium). These findings are relevant to the interpretation of the results of past, present and future clinical studies involving intravenous diazepam. The studies with Valium and Diazemuls confirm the clinical impression of the lesser potency of the latter formulation.
一般认为,静脉注射地西泮不同制剂的生物利用度是相同的。在一项使用8名健康志愿者的受试者自身交叉研究中,我们发现,与有机制剂(安定)相比,乳剂(地西泮乳剂)和胶束制剂注射后,地西泮的初始血浆水平和总体血浆水平均显著降低。这些发现与既往、当前及未来涉及静脉注射地西泮的临床研究结果的解释相关。使用安定和地西泮乳剂的研究证实了后一种制剂效力较低的临床印象。